Albert Seymour, Seamless Therapeutics CEO

Ex­clu­sive: Gene edit­ing start­up Seam­less hires ex-Ho­mol­o­gy leader, dou­bles seed round

A small Ger­man biotech at­tempt­ing to crack in­to the gene edit­ing field with an evolved ap­proach to a decades-old re­search in­ter­est has nabbed for­mer Ho­mol­o­gy …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.